Publication | Closed Access
The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ
20
Citations
38
References
2018
Year
Tumor BiologyInvasive ProgressionMedicinePparγ Agonist EfatutazoneCancer Cell BiologyPathologyCancer BiologyCancer TreatmentDuctal CarcinomaOncologyCell BiologyCancer ResearchEndocrine-related Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1